SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending downwards following a report of security flaws in a communications platform being developed for the U.S. Army, despite the company stating the issues are resolved. The community is debating the validity and timing of the news, with some alleging market manipulation by short sellers. Despite the drop, some bulls are buying the dip, citing the company's long-term potential in AI and government contracts.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to community excitement around its potential connection to rare earth mineral deals with the Trump administration, reminiscent of similar situations with LAC.  The community is actively speculating on upcoming news and the stock's potential, drawing parallels to other rare earth mineral stocks that have surged following government interest. Some investors are also pointing out the valuation discrepancy between CRML and EULIF.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is gaining attention, with community members highlighting its website and Dexscreener link. Advocates express optimism, noting consistent growth, solid volume, and strong community support, while drawing parallels to the broader cultural significance of cannabis. The coin is promoted with the slogan "Like Bitcoin But Way Higher".

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as discussions revolve around recent partnerships and anticipation for upcoming catalysts, including airworthiness certification and piloted VTOL flights. Community members are analyzing the stock's potential to outperform competitors and speculating on future news. Despite positive developments, some traders express frustration with the stock's price action, citing short selling pressures.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is trending amid discussions about its AI investments and potential impact on future growth, with some traders expressing concerns over capital expenditure while others see long-term opportunities. Community members are weighing whether the recent pullback presents a buying opportunity, noting Meta's P/E ratio relative to other tech giants. CoreWeave's soaring stock, fueled by a major AI deal with Meta, is also contributing to the increased interest.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst discussions about potential market manipulation and price targets, with the community debating its true valuation and reacting to volatile price swings. Some traders are taking advantage of the dips while others express frustration over missed profit opportunities, remaining optimistic about long-term growth in the telehealth sector. Recent news and developments may have contributed to the stock's activity.

The project is a groundbreaking memecoin powered by advanced AI that interacts with the community across platforms like X (formerly Twitter). The AI generates unique content, including text, images, videos, music, and animations, all based on current trends. As it learns from user interactions, the AI becomes more responsive, providing engaging and dynamic experiences. Holders are rewarded with exclusive content, voting rights, and governance opportunities, creating an interactive ecosystem that evolves with the community.

Shadow AI

Shadow AI ($SHADOAI) is trending as the community expresses bullish sentiment and anticipates a potential breakout. Discussions highlight its connection to the Solana blockchain and other popular tokens like PEPE and SHIB. The community frames Shadow AI as a hidden gem with significant upside potential in the AI crypto space.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave (QBTS) is trending as excitement builds around quantum computing and recent contract wins fuel optimism. The community is discussing its potential as the 'future Nvidia,' with comparisons to NVDA's early market cap and potential for significant long-term growth. Some are also highlighting the company's potential to reduce energy consumption in data centers and its quantum supremacy.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is trending as the stock experiences a pullback, sparking debates about potential bottom levels and future direction. Community discussions are centered on factors like upcoming earnings, level 1 options, and overall market conditions, with some expressing concern over recent performance while others remain bullish on long-term prospects. Talk of government shutdowns, analyst ratings, and comparisons to similar companies are also influencing the conversation.

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.

Black Titan Corp.

BTTC is trending due to a recent merger, leading to significant after-hours gains and a high short interest. The community is discussing its low float and potential for further upward movement, with some drawing comparisons to other high-flying stocks. Some traders are also noting its similarity in ticker name to "BTC", and the stock's connection to energy solutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last?

Karyopharm Therapeutics (KPTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of -13.68% and -5.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of +3.70% and +4.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

United Therapeutics (UTHR) Misses Q2 Earnings Estimates

United Therapeutics (UTHR) delivered earnings and revenue surprises of -5.74% and +0.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Karyopharm Therapeutics (KPTI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Karyopharm Therapeutics (KPTI) Is a Great 'Buy the Bottom' Stock Now

Does Karyopharm Therapeutics (KPTI) Have the Potential to Rally 521.62% as Wall Street Analysts Expect?

Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates

Karyopharm Announces 1-for-15 Reverse Stock Split

Karyopharm Announces 1-for-15 Reverse Stock Split Karyopharm Announces 1-for-15 Reverse Stock Split PR Newswire NEWTON, Mass., Feb. 24, 2025 NEWTON, Mass., Feb. 24, 2025 /PRNewswire/ -- Karyopharm...

Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress

Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress Karyopharm Reports Fourth Quarter and...

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$6.38
Prev Close	$6.29
Open	$6.29
Dividend Yield	0.00%
50-Day Moving Average	$5.73
Beta	1.22
Avg. Volume	96,540.86
PE Ratio	-0.43

52-Week High	$16.95
52-Week Low	$3.51
Market Capitalization	$54.54M
EPS (Annual)	-$9.41
Price to Book	-0.23
Revenue Per Employee	$520,562.72
Enterprise Value/EBITDA	N/A

KPTI
Karyopharm Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KPTI News

KPTI Karyopharm Therapeutics Inc